Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)
CNY 11.24
(-0.79%)
CNY 11.24
(-0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.42 Billion | 7.15 Billion | 6.36 Billion | 5.33 Billion | 4.62 Billion | 4.81 Billion |
| Cost of Revenue | 4.5 Billion | 4.82 Billion | 4.33 Billion | 3.24 Billion | 2.89 Billion | 2.88 Billion |
| Gross Profit | 921.02 Million | 2.33 Billion | 2.03 Billion | 2.08 Billion | 1.72 Billion | 1.93 Billion |
| Operating Expenses | 2.66 Billion | 1.21 Billion | 1.06 Billion | 960.97 Million | 896.49 Million | 845.39 Million |
| Selling, General and Administrative Expenses | 906.83 Million | 664.99 Million | 572.83 Million | 559.66 Million | 539.64 Million | 416.26 Million |
| Research and Development Expenses | 184.66 Million | 252.14 Million | 221.09 Million | 160 Million | 148.71 Million | 186.85 Million |
| Other Expenses | 1.88 Billion | 294.71 Million | 274.94 Million | 241.3 Million | 208.13 Million | 9.7 Million |
| Cost and Expenses | 6.19 Billion | 6.03 Billion | 5.4 Billion | 4.2 Billion | 3.79 Billion | 3.73 Billion |
| Operating Income | -259.94 Million | 1.13 Billion | 773.2 Million | 1.32 Billion | 1.31 Billion | 721.14 Million |
| Interest Expense | 223.21 Million | 235.24 Million | 201.63 Million | 247.71 Million | 257.8 Million | 199.53 Million |
| Income Tax Expense | 126.17 Million | 115.16 Million | -11.12 Million | 306.2 Million | 271.38 Million | 138.66 Million |
| Earnings before Tax | -480.38 Million | 829.85 Million | 222.26 Million | 1.32 Billion | 1.31 Billion | 730.84 Million |
| Net Income | -783.25 Million | 727.42 Million | 240.78 Million | 1.02 Billion | 1.05 Billion | 616.19 Million |
| Earnings Per Share Basic | -0.53 | 0.50 | 0.16 | 0.76 | 0.85 | 0.49 |
| Earnings Per Share Diluted | -0.53 | 0.50 | 0.16 | 0.76 | 0.85 | 0.49 |
| Weighted Average Shares Outstanding | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.35 Billion | 1.24 Billion | 1.24 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.35 Billion | 1.24 Billion | 1.24 Billion |
| Gross Margin | 0.17 | 0.33 | 0.32 | 0.39 | 0.37 | 0.40 |
| EBIT Margin | 0.02 | 0.20 | 0.17 | 0.37 | 0.42 | 0.25 |
| Profit Margin | -0.14 | 0.10 | 0.04 | 0.19 | 0.23 | 0.13 |
| EBITDA | 124.71 Million | 1.37 Billion | 867.67 Million | 1.67 Billion | 1.83 Billion | 1.12 Billion |
| Earnings Before Tax Margin | -0.05 | 0.16 | 0.12 | 0.25 | 0.28 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.22 Billion | 1.46 Billion | 1.36 Billion | 1.37 Billion | 5.42 Billion | 1.35 Billion |
| Cost of Revenue | 868.77 Million | 949.59 Million | 899.55 Million | 949.84 Million | 3.74 Billion | 963.78 Million |
| Gross Profit | 359.25 Million | 514.55 Million | 468.72 Million | 421.38 Million | 1.67 Billion | 386.54 Million |
| Operating Expenses | 243.87 Million | 247.73 Million | 178.41 Million | 1.27 Billion | 1.93 Billion | 233.56 Million |
| Selling, General and Administrative Expenses | 209.24 Million | 84.48 Million | 176.87 Million | 263.54 Million | - | 330.52 Million |
| Research and Development Expenses | 48.93 Million | 45.74 Million | 35.29 Million | 27.69 Million | - | 56.86 Million |
| Other Expenses | 14.3 Million | -50.78 Thousand | 33.75 Million | -983.4 Million | -855.37 Million | -21.48 Million |
| Cost and Expenses | 1.11 Billion | 1.19 Billion | 1.07 Billion | 2.22 Billion | 5.68 Billion | 1.19 Billion |
| Operating Income | 115.37 Million | 586.49 Million | 290.3 Million | -853.24 Million | -259.94 Million | 14.86 Million |
| Interest Expense | 30.98 Million | 34.42 Million | 45.13 Million | 51.03 Million | 223.21 Million | 56 Million |
| Income Tax Expense | 3.33 Million | 78.2 Million | 26.6 Million | -165.46 Million | -126.17 Million | -6.07 Million |
| Earnings before Tax | 131.85 Million | 586.44 Million | 227.39 Million | -944.79 Million | -480.38 Million | 13.44 Million |
| Net Income | 116.43 Million | 508.64 Million | 155.04 Million | -926.42 Million | -783.25 Million | 19.82 Million |
| Earnings Per Share Basic | 0.08 | 0.35 | 0.11 | -0.63 | - | 0.01 |
| Earnings Per Share Diluted | 0.08 | 0.35 | 0.11 | -0.63 | - | 0.01 |
| Weighted Average Shares Outstanding | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion |
| Gross Margin | 0.29 | 0.35 | 0.34 | 0.31 | 0.31 | 0.29 |
| EBIT Margin | 0.13 | 0.52 | 0.12 | -0.55 | - | 0.03 |
| Profit Margin | 0.09 | 0.35 | 0.11 | -0.68 | -0.14 | 0.01 |
| EBITDA | 162.84 Million | 757.84 Million | 159.9 Million | -747.4 Million | - | 40.9 Million |
| Earnings Before Tax Margin | 0.09 | 0.40 | 0.21 | -0.62 | -0.05 | 0.01 |
0QKA
NBS
4028
0OHK
2237
601665